Cardiac fibrosis
Open accessThe DOI matches its Crossref record; 612 of the 615 references it cites were found in a registry or an index.
Abstract
Myocardial fibrosis, the expansion of the cardiac interstitium through deposition of extracellular matrix proteins, is a common pathophysiologic companion of many different myocardial conditions. Fibrosis may reflect activation of reparative or maladaptive processes. Activated fibroblasts and myofibroblasts are the central cellular effectors in cardiac fibrosis, serving as the main source of matrix proteins. Immune cells, vascular cells and cardiomyocytes may also acquire a fibrogenic phenotype under conditions of stress, activating fibroblast populations. Fibrogenic growth factors (such as transforming growth factor-β and platelet-derived growth factors), cytokines [including tumour necrosis factor-α, interleukin (IL)-1, IL-6, IL-10, and IL-4], and neurohumoral pathways trigger fibrogenic signalling cascades through binding to surface receptors, and activation of downstream signalling cascades. In addition, matricellular macromolecules are deposited in the remodelling myocardium and regulate matrix assembly, while modulating signal transduction cascades and protease or growth factor activity. Cardiac fibroblasts can also sense mechanical stress through mechanosensitive receptors, ion channels and integrins, activating intracellular fibrogenic cascades that contribute to fibrosis in response to pressure overload. Although subpopulations of fibroblast-like cells may exert important protective actions in both reparative and interstitial/perivascular fibrosis, ultimately fibrotic changes perturb systolic and diastolic function, and may play an important role in the pathogenesis of arrhythmias. This review article discusses the molecular mechanisms involved in the pathogenesis of cardiac fibrosis in various myocardial diseases, including myocardial infarction, heart failure with reduced or preserved ejection fraction, genetic cardiomyopathies, and diabetic heart disease. Development of fibrosis-targeting therapies for patients with myocardial diseases will require not only understanding of the functional pluralism of cardiac fibroblasts and dissection of the molecular basis for fibrotic remodelling, but also appreciation of the pathophysiologic heterogeneity of fibrosis-associated myocardial disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inflammation and tissue fibrosis co-exist and are causally linked to organ dysfunction1,2.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [2]
In the citing paper
“Among stromal cell types, fibroblasts are of particular interest given their role in tissue fibrosis, arrhythmias, and heart failure 16,29,30 .”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [30]
Citations
Cites
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495 · cited 1×
“Fibrosis is an important cause of organ dysfunction in many different diseases, including interstitial lung diseases, liver cirrhosis, progressive systemic sclerosis, and diabetic nephropathy.(1)”
BackgroundMyofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093
Ignotz, R. A., & Massagué, J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35666-1 · Cited by 2,492
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
Desmoulière, A., Geinoz, A., Gabbiani, F., & Gabbiani, G. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.103 · Cited by 2,243
The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis
Prabhu, S. D., & Frangogiannis, N. G. (2016) · Circulation Research · doi:10.1161/circresaha.116.303577 · Cited by 2,224
Self-citationEndothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222 · cited 2×
“The antifibrotic effects were attributed to blockade of TGF-b signalling and were associated with attenuated endothelial to mesenchymal transition.(22,247) Moreover, gain-of-function studies have”
BackgroundHinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068
Cited by
Items 601–700 of 1,000
Xiong, Y., Alnoud, M. A. H., Ali, H., Ali, I., Ahmad, S., Khan, M. U., Hassan, S. S. U., Majid, M., Khan, M. S., Ahmad, R. U. S., et al. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102390 · Cited by 7
Chitosan Versus Dapagliflozin in a Diabetic Cardiomyopathy Mouse Model
Târtea, G. C., Popa‐Wagner, A., Sfredel, V., Mitran, S. I., Dan, A. O., Țucă, A.-M., Preda, A. N., Raicea, V. C., Țieranu, E. N., Cozma, D. C., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042118 · Cited by 7
Yokokawa, T., Nishiura, K., Katahira, M., Sato, Y., Miura, S., Sato, A., Shimizu, T., Misaka, T., Sato, T., Kaneshiro, T., et al. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.04.016 · Cited by 8
Unraveling the Etiology of Dilated Cardiomyopathy through Differential miRNA–mRNA Interactome
Bonet, F., Hernández‐Torres, F., Ramos, M., Quezada-Feijoó, M., García, A. B., Daroca, T., Alonso-Villa, E., García‐Padilla, C., Mangas, A., & Toro, R. (2024) · Biomolecules · doi:10.3390/biom14050524 · Cited by 8
Zanetti, M., Braidotti, N., Khumar, M., Montelongo, E., Lombardi, R., Sbaizero, O., Mestroni, L., Taylor, M. R. G., Baj, G., Lazzarino, M., et al. (2024) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2024.106571 · Cited by 7
Tudurachi, B.-S., Anghel, L., Tudurachi, A., Sascău, R. A., Zanfirescu, R.-L., & Stătescu, C. (2024) · Biomedicines · doi:10.3390/biomedicines12061314 · Cited by 7
“Smad3 signaling in myofibroblasts within the infarcted area inhibits cell proliferation, resulting in organized clusters of activated myofibroblasts and maintaining structural integrity through integrin and reactive oxygen species (ROS)-mediated pathways [2,7,28].”
InfluentialGuo, Y., Ji, S., Rong, S., Hong, W., Ding, J., Yan, W., Qin, G., Li, G., & Sang, N. (2024) · Environmental Science & Technology · doi:10.1021/acs.est.4c00735 · Cited by 7
Cayer, L. G. J., Buhrke, T., Roberts, J., Nunnikhoven, A., Sommerkorn, K., Reinhold, A., Braeuning, A., Raju, J., Aukema, H. M., & Karakach, T. K. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03856-6 · Cited by 8
Zhou, Z., Hughes, K., Saif, N., Kim, H., Massett, M. P., Zheng, M., Cecchi, A. C., Guo, D., Murdock, D. R., Pan, P., et al. (2025) · PLoS Genetics · doi:10.1371/journal.pgen.1011394 · Cited by 7
“One key driver is the activation of the renin-angiotensin-aldosterone system due to decreased stroke volume and renal blood flow [39], facilitating fibroblast proliferation and collagen deposition in the myocardium [40,41].”
Long Non-Coding RNAs in Cardiac and Pulmonary Fibroblasts and Fibrosis
Ilieva, M. S., & Uchida, S. (2022) · Non-Coding RNA · doi:10.3390/ncrna8040053 · Cited by 7
“, myocardial infarction, cardiac hypertrophy) result in cardiac fibrosis, where cardiac fibroblasts are activated to become myofibroblasts to deposit excess extracellular matrices [21,22].”
BackgroundAchlaug, L., Awwad, L., Goncalves, I. L., Goldenberg, T., & Aronheim, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612595 · Cited by 7
“Pathophysiological fibrosis is observed in several diseases, including ones involving the liver [3], heart [4,5], skeletal muscles [6], kidneys [7], and lungs [8].”
BackgroundECM Substrates Impact RNAi Localization at Adherens Junctions of Colon Epithelial Cells
Daulagala, A. C., & Kourtidis, A. (2022) · Cells · doi:10.3390/cells11233740 · Cited by 7
Wáng, Y., Bai, L., Wen, J., Zhang, F., Gu, S., Wang, F., Yin, J., & Wang, N. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1061146 · Cited by 7
“Cardiomyocytes can promote cardiac fibrosis by activating pro-fibrogenic programming (39, 42), and CFs promote cardiomyocyte hypertrophy by secreting growth cytokines in pathological conditions (43, 44).”
BackgroundInfluentialMacrophages and fibroblasts in cardiac fibrosis: interactions and transformation
Kim, D., & Baek, J.-H. (2025) · Exploration of Immunology · doi:10.37349/ei.2025.1003211 · Cited by 6
Physiological Mechanisms Vulnerable to Alcohol‐Induced Alterations: Role in Chronic Comorbidities
Simon, L., Couvillion, K. E., Donovan, M. E., Gallegos, E. M., Souza‐Smith, F. M., & Molina, P. E. (2025) · Comprehensive physiology · doi:10.1002/cph4.70057 · Cited by 7
RNA Therapeutics in Heart Failure
Deiman, F. E., de Graaf, M. M., Silljé, H. H. W., Beverborg, N. G., Bömer, N., & van der Meer, P. (2025) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-025-10717-9 · Cited by 7
“Increased collagen deposition leads to extracellular matrix (ECM) remodelling by disrupting cell–matrix interactions, exacerbating pathological processes and ultimately impairing cardiac function [113, 114].”
Jia, Y., Yin, T., Wang, Z., Chen, L., Fan, H., Wu, J., Yu, Q., Zhang, Y., & Shen, Z. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.102854 · Cited by 6
“Myocardial fibrosis significantly contributes to adverse cardiac remodeling and contractile dysfunction following MI [45].”
InfluentialZivalj, D., Schleicher, L. M. S., Kršek, A., Diamee, H. J. F., Raljević, D., & Batičić, L. (2026) · Life · doi:10.3390/life16030400 · Cited by 7
Early Development of Cardiac Fibrosis in Young Old‐Father Offspring
Ismail, A., Saliba, Y., & Farès, N. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8770136 · Cited by 6
“Our results align with the published literature regarding the development of cardiac fibrosis in a hypertension animal model [23].”
Sedmera, D., Kvasilová, A., Eckhardt, A., Kačer, P., Pěnička, M., Kocka, M., Schindler, D., Kaban, R., & Kočková, R. (2024) · Histochemistry and Cell Biology · doi:10.1007/s00418-024-02268-y · Cited by 6
“Cardiac fibrosis is commonly defined as excessive deposition of the extracellular matrix (ECM), mostly collagen, in the myocardial interstitial space (Frangogiannis 2021).”
Backgroundm6A RNA methylation: The latent string-puller in fibrosis
He, X., Tang, B., Zou, P., Song, Z., Liu, J., Pi, Z., Xiao, Y., & Xiao, R. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122644 · Cited by 6
Li, L., Gao, J., Liu, X., Chen, B.-X., Su, P., & Xie, B. (2024) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytae189 · Cited by 6
Zha, Y., Luo, X., Ge, Z., Zhang, J., Li, Y., & Zhang, S. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167473 · Cited by 7
Caudal, A., Liu, Y., Pang, P. D., Maison, D. P., Nakasuka, K., Feng, J., Sperber, H. S., Schwarzer, R., Moffatt, E., Henrich, T. J., et al. (2024) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2024.08.013 · Cited by 6
Wang, J., Liu, X., Zhu, R., Sun, Y. H., Jiao, B., Wang, K., Jiang, Y., Wang, Y., Li, C., & Wang, W. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.04.025 · Cited by 6
Radiation-Induced Cardiac Remodeling: Mechanisms and Therapeutic Approaches
Ghnim, Z. S., Adhab, A. H., Mahdi, M. S., Kyada, A., Roopashree, R., Thakur, V., Kaur, M., Gupta, A., Mansoor, A. S., Radi, U. K., et al. (2025) · Cardiovascular Toxicology · doi:10.1007/s12012-025-10006-6 · Cited by 6
“This process is characterized by the excessive deposition of extracellular matrix (ECM) components, leading to myocardial and vascular stiffening, which can lead to impaired cardiac function [129].”
Zheng, Y., Wei, H., Tian, Y., Yun, M., Mou, T., Lu, Y., Tian, J., Meng, J., Wang, Y., Hacker, M., et al. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07363-3 · Cited by 6
“The significant interplay between inflammatory response and fibro - blast activation plays a crucial role in MI toward cardiac remodeling pathogenesis [ 2].”
Ma, L., Lu, B., Si, Y., Dai, L., Tan, M., Liu, W., Sun, D., Shu, J., Chen, C., Xiang, Q., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110421 · Cited by 7
“The transdifferentiation of cardiac fibroblasts into myofibroblasts plays a pivotal role in the progression of cardiac fibrosis (14).”
Tikhomirov, R., Boichenko, V., Reilly-O’Donnell, B., Lucarelli, C., Srivastava, P. K., Anwar, M., Yiu, C. H. K., Dielesen, J., Noakes, V. M., Piella, S. N., et al. (2026) · Circulation Research · doi:10.1161/circresaha.125.326799 · Cited by 6
Isono, T., Matsumoto, T., Suzaki, M., Kubota, S., Kageyama, S., Kawauchi, A., & Wada, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-26717-7 · Cited by 6
Meyer, F., Santos, G. L., Doan, T. P., DeGrave, A. N., Bues, B., & Lutz, S. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02421-9 · Cited by 6
Rong, Y., Zhou, X., Guo, Z., Zhang, Y., Qin, W., Li, L., Si, J., Yang, R., Li, X., & Ma, K. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023083 · Cited by 6
Tan, Y., Cao, L., Jiao, Y.-Q., Han, L., Tang, M., Wang, Z., Zhang, W., Zhong, M., & Zhong, M. (2023) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2023.111996 · Cited by 6
Cheng, X., Zhang, Y., Guo, H., Li, X., Wang, Y., Song, Y., Wang, H., & Ma, D. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3758 · Cited by 6
“It reflects the repair of fibrotic response of cardiomyocyte necrosis, the release of fibroblast mediators by stimulated cardiomyocytes, or the activation of immune cells (Frangogiannis, 2021).”
BackgroundZhao, X., Qin, Y., Wang, B., Liu, J., Wang, Y., Chen, K., Zhao, J., Zhang, L., Wu, Y., & Liu, L. (2024) · Nanoscale Advances · doi:10.1039/d4na00042k · Cited by 6
Targeting SOCS2 alleviates myocardial fibrosis by reducing nuclear translocation of β-catenin
Yuan, M., Shi, H., Wang, B., Cai, J., Yu, W., Wang, W., Qian, Q., Wang, Y., Zhou, X., & Liu, J. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119804 · Cited by 7
Accioli, R., Lazzerini, P. E., Salvini, V., Cartocci, A., Verrengia, D., Marzotti, T., Salvadori, F., Bisogno, S., Cevenini, G., Voglino, M., et al. (2024) · Journal of Arrhythmia · doi:10.1002/joa3.13114 · Cited by 7
“28 In fact, besides promoting in the medium long-term cardiac fibrosis 48 (a well-accepted mechanism for ab - normal impulse propagation), 49 several experimental and trans - lational studies provided substantial evidence that inflammatory cytokines can rapidly induce gap-junction dysfunction in…”
BackgroundDACT2 modulates atrial fibrillation through TGF/β and Wnt signaling pathways
Luo, B., Zheng, R., Shi, C., Chen, D., Jin, X., Hou, J., Xu, G., & Hu, B. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36050 · Cited by 6
Luo, C., Tan, B., Chu, L., Chen, L., Zhong, X., Jiang, Y., Yan, Y., Mo, F., Wang, H., & Yang, F. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1460813 · Cited by 6
Comparative phenotyping of C57BL/6J substrains reveals distinctive patterns of cardiac aging
Walter, S., Owesny, P., Hegemann, N., Häseli, S. P., Deubel, S., Jelleschitz, J., Höhn, A., Berndt, N., Kuebler, W. M., Grune, J., et al. (2025) · GeroScience · doi:10.1007/s11357-025-01543-7 · Cited by 7
“However, recruitment of CD45-positive cells may not be necessary for age-related fibrosis, since the production of extracellular matrix is mediated by fibroblasts/ myofibroblasts [37].”
Hu, M., Huang, S., Gao, Y., Hu, Y., Wang, S., Teng, T., Zeng, X., & Tang, Q. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.037455 · Cited by 6
“60 Previous studies verified that TGF-β plays a crucial role in the mechanisms by which the KLF family mediates related diseases.”
Maroney, S. A., Siebert, A. E., Martinez, N. D., Rasmussen, M. A., Peterson, J. A., Weiler-Guettler, H., Lincoln, J., & Mast, A. E. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2022.11.034 · Cited by 6
Huang, Q., Ma, J., Wu, H., Zhou, J., Jiang, L., & Fei, X. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2807155 · Cited by 6
Abecasis, J., Lopes, P. M., Maltês, S., Santos, R. R., Ferreira, A. M., Ribeiras, R., Andrade, M. J., Sousa‐Uva, M., Gil, V. M., Félix, A., et al. (2024) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeae023 · Cited by 6
Fibrosis modeling choice affects morphology of ventricular arrhythmia in non-ischemic cardiomyopathy
Myklebust, L., Maleckar, M. M., & Arevalo, H. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1370795 · Cited by 8
“In non-cleft c models, we used a conductivity of 0.01 S/m based on experimental measurements of collagen (Bishop et al., 2010), representing dense interstitial fibrosis (Frangogiannis, 2021).”
MethodInfluentialYuan, J., Su, Z., Wang, G., Yang, K., Zhang, B., Ma, K., Zhang, S., Yang, Y., Feng, Z., Mao, F., et al. (2023) · Interdisciplinary CardioVascular and Thoracic Surgery · doi:10.1093/icvts/ivad023 · Cited by 6
Stem cell antigen-1+cell-derived fibroblasts are crucial for cardiac fibrosis during heart failure
Tao, T., Du, L., Teng, P., Guo, Y. P., Wang, X., Hu, Y., Zhao, H., Xu, Q., & Ma, L. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04957-8 · Cited by 5
“Cardiac fibroblasts are not only a major cell population in the heart that play a critical role in maintaining normal cardiac function, but also the effective cells as they become activated and proliferative contributing to myocardial hypertrophy under different conditions [3, 4, 6].”
BackgroundChen, L., Chen, L., Shen, H.-W., Hsu, C., Zeng, J., Li, J.-H., Liu, J., Yang, J.-Z., Liu, Y., Li, X., et al. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117185 · Cited by 6
Sex Differences in Response to Diet Enriched With Glutathione Precursors in the Aging Heart
Angelini, A., Marquez, G. G., Malovannaya, A., Fiorotto, M. L., Saltzman, A. B., Jain, A., Trial, J., Taffet, G. E., & Cieslik, K. A. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae258 · Cited by 5
Decoding the regulatory roles of circular RNAs in cardiac fibrosis
You, Q., Yu, J., Pan, R., Feng, J., Guo, H.-D., & Liu, B. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.11.007 · Cited by 6
“…infarction (MI), characterized by reparative or replacement fibrosis [4] or non-ischemic conditions involving chronic inflammation and edema, which lead to reactive fibrosis [5], the necrosis or apoptosis of cardiomyocytes (CMs) alongside CF activation result in excessive accumulation of ECM [6].”
YTHDF3-mediated FLCN/cPLA2 axis improves cardiac fibrosis via suppressing lysosomal function
Zhang, Y., Diao, H., Leng, M., Wu, Y.-Z., Huang, B.-Y., Li, X., Tang, W.-Y., Wu, K., Tan, H.-L., Wang, L., et al. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01425-2 · Cited by 5
Recent Advances in Hydrogel-Based 3D Disease Modeling and Drug Screening Platforms
Bilginer-Kartal, R., Çoban, B., Yildirim-Semerci, Ö., & Yıldız, A. A. (2025) · Advances in experimental medicine and biology · doi:10.1007/5584_2025_851 · Cited by 7
Yi, X., Abas, R., Rooshdi, R. A. W. R. M., Yan, J., Liu, C., An, J., & Daut, U. N. (2025) · Scientific Reports · doi:10.1038/s41598-025-01587-x · Cited by 5
Karim, S.-U., Nazneen, F., Denyoh, P. M. D., Bai, D. S., Romero, D. G., & Bai, F. (2025) · Scientific Reports · doi:10.1038/s41598-025-02191-9 · Cited by 5
The multifaced role of the macrophage migration inhibitory factor family in organ fibrosis
Herkens, L., Droste, P., & Boor, P. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00198.2025 · Cited by 5
Zhang, Q., Cai, Z., & Zhang, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-00260-7 · Cited by 7
Narducci, M. L., Conte, C., Telesca, A., Liuzzo, G., & Imazio, M. (2025) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2025.05.006 · Cited by 5
Maestro, D., Palanca, A., Soto, H., Llarena, I., DeGrave, A. N., Guedes, G., Oliveira, G., Conceição, A. L. C., Mieites, V., Icardo, J. M., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113013 · Cited by 5
Saravanan, J. A. M., Ali, A., & Katare, R. (2025) · The FASEB Journal · doi:10.1096/fj.202501226rr · Cited by 8
“Cardiac fibrosis is the excessive accumulation of ECM in the heart muscle, leading to stiffening heart walls and cardiac dysfunction [61, 62].”
Luteolin for the Treatment of Organ Fibrosis: A Mini Review
Wang, N., & Lan, W. (2025) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575408729250811073556 · Cited by 5
Epigenetic regulation of extracellular matrix mechanotransduction in cardiac fibrosis
Lin, L.-C., Liu, Z., Mao, S., Liu, P., Yang, J.-J., Zhao, J., & Tao, H. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117325 · Cited by 5
Hata, R., Funakoshi, S., Makiyama, T., Kato, T., Narita, M., Matsumura, Y., Hirohata, R., Naka, Y., Ida, K., Ito, H., et al. (2025) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2025.101363 · Cited by 6
Lv, M., Yi-lin, Y., Niu, H., & Yu, D. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152644 · Cited by 5
Sun, X., Sigal, S., Cosma, M.-A., Villiers, C. D., Weinberger, M., & Riley, P. R. (2025) · npj Regenerative Medicine · doi:10.1038/s41536-025-00430-1 · Cited by 7
Unraveling the interplay between RAS axes and NOX signaling in fibroblasts during cardiac fibrosis
Chaturvedi, G., Chauhan, A., Dubey, N., Seth, S., Bhatia, J., Yadav, S. C., & Yadav, H. N. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05400-1 · Cited by 5
Zhang, H., Xu, J., Li, W., Wang, Z., Wang, Z., & Liu, K. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157371 · Cited by 5
Chen, P., Hsiao, C., Chiang, S.-J., Lin, Y., Chung, K., & Tsai, S. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120525 · Cited by 5
Engineered immune-driven theranostics for clinical cardiology
Zheng, J.-B., Li, X., Zhu, J., Liu, C., Song, X., Wang, B., Deng, Y. W., Feng, Y.-X., Wang, Q., Liu, J., et al. (2025) · Military Medical Research · doi:10.1186/s40779-025-00664-6 · Cited by 5
“Immune cells, including macrophages, neutrophils, T cells, and B cells, regulate cytokine and protease release, phagocytose debris, and undergo phenotypic switching or programmed death, thereby orchestrating vascular remodeling and ECM turnover [33–36].”
Shiel, E. A., Farra, W., Medarev, S. L., Ariyaratne, G. H. D. N., Cannon, E. N., Steiner, J. L., & Chelko, S. P. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00416.2025 · Cited by 5
Gemayel, J.-A., Chatelier, A., Bois, P., & Farès, N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031582 · Cited by 8
Molecular Mechanisms of Cardiac Fibrosis: A Pathologist’s Perspective
Marzullo, A., & Salzillo, C. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48030278 · Cited by 5
“A commonly adopted classification distinguishes interstitial fibrosis, perivascular fibrosis and replacement fibrosis, each with specific morphological characteristics and functional significance [7,8].”
Kazemi-Lari, M. A., Shaw, J. A., Wineman, A. S., Shimkunas, R., Jian, Z., Hegyi, B., Izu, L. T., & Chen‐Izu, Y. (2022) · iScience · doi:10.1016/j.isci.2022.104667 · Cited by 5
Immune heterogeneity in cardiovascular diseases from a single-cell perspective
Su, X., Wang, L., Ma, N., Yang, X., Liu, C., Yang, F., Li, J., Yi, X., & Xing, Y. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1057870 · Cited by 5
Suppression of Heart Failure With PAR1 Pepducin Technology in a Pressure Overload Model in Mice
Fletcher, E. K., Ngwenyama, N., Nguyen, N., Turner, S. E., Covic, L., Alcaide, P., & Kuliopulos, A. (2023) · Circulation Heart Failure · doi:10.1161/circheartfailure.123.010621 · Cited by 6
Harnessing stem cell and lineage reprogramming technology to treat cardiac fibrosis
Zeng, N., Tang, W., Wu, Y., Fan, H., Xie, S., & Cao, N. (2023) · Cell Regeneration · doi:10.1186/s13619-023-00182-7 · Cited by 5
Advances in the Study of MG53 in Cardiovascular Disease
Liu, S.-M., Zhao, Q., Li, W.-J., & Zhao, J. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s435030 · Cited by 5
“59 Additionally, inhibiting MG53 through tail vein delivery of TRIM72-shRNA significantly reduced the deposition of collagen, including type I collagen and α-smooth muscle actin, in angiotensin II-stimulated cardiac fibroblasts.”
BackgroundZhang, W., Zhang, Y., Xia, Y., Feng, G., Wang, Y., Wei, C., Tang, A., Song, K., Qiu, R., Wu, Y., et al. (2023) · Physiological Research · doi:10.33549/physiolres.935075 · Cited by 5
Roy, A., Hao, L., Francisco, J. J., Guan, J., Mareedu, S., Zhai, P., Dodd‐o, J., Heffernan, C., Re, D. P. D., Lee, E. J., et al. (2024) · Biomacromolecules · doi:10.1021/acs.biomac.3c01345 · Cited by 5
Chen, Y., Bao, L., Dong, F., Xv, M., Li, W., Luo, T., Xing, C., Yan, N., Niu, K., Zhang, N., et al. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111401 · Cited by 5
Ding, Y., Wei, J., Ji, E., Wang, M., Wu, Y., Chang, M., Zhang, Y., & Xu, J. (2024) · Science of Traditional Chinese Medicine · doi:10.1097/st9.0000000000000040 · Cited by 5
Emerging roles of ketone bodies in cardiac fibrosis
Maduray, K., & Zhong, J. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00241.2024 · Cited by 5
Handra, J., James, H., Mbilinyi, A., Moller‐Hansen, A., O'Riley, C., Andrade, J. G., Deyell, M. W., Hague, C. J., Hawkins, N. M., Ho, K., et al. (2024) · JMIR Cardio · doi:10.2196/60697 · Cited by 6
Ponomareva, O. V., & Смирнова, Е. А. (2024) · Nauka molodykh (Eruditio Juvenium) · doi:10.23888/hmj2024122303-316 · Cited by 5
Ge, L., Ma, J., Xu, J., Wang, W., Adil, A., & Xu, H. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111650 · Cited by 5
Jiao, R., Li, W., Gu, X., Liu, J., Liu, Z., Hu, Y., Yang, Z., Liu, Y., Liu, X., Gu, R., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114848 · Cited by 6
Dedifferentiation of Human Cardiac Myofibroblasts Is Independent of Activation of COX-2/PGE2 Pathway
Luu, V. T., Phan, S., & Jin, Z.-Q. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063023 · Cited by 5
Zhai, Y., Li, J., Peng, L., Lu, G., & Gao, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315061 · Cited by 5
“Th se int acel ula regulatory mechanisms of AVP in aldosterone synthesis in the local heart may have an importa t impl tion in cli ical medicine. i titi l fi i , t i i iti , is a co pensatory response secondary to AMI [2].”
BackgroundInfluentialRole of cGAS-STING signaling pathway in cardiometabolic diseases.
Ding, H., Zhou, Y., Yin, Z., & Tai, S. (2023) · PubMed Central · doi:10.11817/j.issn.1672-7347.2023.230028 · Cited by 5
Xu, S.-T., Zhang, Y., Liu, S.-L., Liu, F., & Ye, J. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.10.031 · Cited by 5
Xu, Y., Zheng, Z., Pan, H., Zhao, M., Zhang, J., Peng, S., Liu, J., Pan, W. D., Yin, Z., Xu, S., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202301841r · Cited by 5
“3 Therefore, targeting the activation and proliferation of cardiac fibroblasts (CFs) may serve as a critical therapeutic strategy for cardiac remodeling.”
BackgroundKolesar, D. M., Kujal, P., Mrázová, I., Pokorný, M., Škaroupková, P., Sadowski, J., Červenka, L., & Netuka, I. (2024) · Physiological Research · doi:10.33549/physiolres.935217 · Cited by 5
“…conclusion that sex-linked differences in the course of unloading-induced cardiac atrophy cannot be simply ascribed to the presence of sex hormones is based on the classical experimental approach to explore sex-linked differences, i.e. on the comparison of intact and gonadectomized animals [11,54].”
BackgroundAge-related trends of ischemic sudden cardiac death in women
Hookana, I., Eskuri, M. A. E., Holmström, L., Vähätalo, J., Kenttä, T. V., Tikkanen, J. T., Pakanen, L., Perkiömäki, J. S., Huikuri, H., & Junttila, J. M. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132238 · Cited by 5
Sillett, C., Razeghi, O., Baptiste, T. M. G., Lee, A., Solís-Lemus, J. A., Rodero, C., Roney, C. H., Feng, R., Ganesan, P., Chang, H. J., et al. (2025) · European Heart Journal - Imaging Methods and Practice · doi:10.1093/ehjimp/qyaf027 · Cited by 5
Jiao, T., Wang, Y., Lin, X., Song, W., Wang, L., Tapu, S. R., Xu, L., Nie, L., Zhang, Q., & Li, J. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1256156 · Cited by 6
“Emerging evidence indicates that functional cardiomyocytes have the potential to stimulate interstitial fibroblasts during periods of stress, thereby promoting the development of interstitial fibrosis (41).”
BackgroundSmall Leucine Rich Proteoglycan in Fibrotic Diseases: New Frenemies?
Guo, J., Wang, Y., Liang, H., & Yang, B. (2023) · International Journal of Drug Discovery and Pharmacology · doi:10.53941/ijddp.2023.100005 · Cited by 5
Direct interrogation of context-dependent GPCR activity with a universal biosensor platformPreprint
Janicot, R., Maziarz, M., Park, J., Luebbers, A., Green, E., Zhao, J., Philibert, C. E., Zhang, H., Layne, M. D., Wu, J. C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.02.573921 · Cited by 6
Tao, W., Gong, M., & Ke, Z. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70554 · Cited by 4
“Additionally, Mast cells, identified by CPA3, were also enriched in DCM (Figure 2D), potentially influencing the activation of myofibroblasts [19].”
Proteomic profiling of the extracellular matrix in skeletal muscle
Swandulla, D., & Ohlendieck, K. (2025) · Advances in clinical chemistry · doi:10.1016/bs.acc.2025.06.008 · Cited by 4
Sharew, B., Chikwe, J., Sallam, A., Razavi, A. A., Tam, D. Y., Nowacki, A. S., Egorova, N., Emerson, D. A., Bowdish, M. E., & Blackstone, E. H. (2025) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2025.08.017 · Cited by 4
Li, Y., Feng, C., Zu, Y., Long, P., & Chen, A. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112105 · Cited by 4
Metadata
- Authors
- Frangogiannis, N. G.
- Affiliations
- Albert Einstein College of Medicine (US)
- Corresponding author
- Frangogiannis, Nikolaos G
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-11-02
- Volume
- 117
- Issue
- 6
- Pages
- 1450-1488
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- PMC
- PMC8152700
- OpenAlex
- W4210607007
- Cited by
- 1,229
- References
- 615
- Citations by year
- 2026: 265 · 2025: 319 · 2024: 273 · 2023: 210 · 2022: 130 · 2021: 32
- FWCI
- 15.82
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Cardiovascular Research (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- NIH (R01 HL76246, R01 HL85440, R01 HL149407)
- U.S. Department of Defense (PR151134, PR151029, PR181464)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- myocardial fibrosis, myocardial fibroblasts, myofibroblasts, extracellular matrix deposition, TGF-beta, platelet-derived growth factor, cytokines, mechanoreceptors, integrins, pressure overload, myocardial infarction, heart failure, familial cardiomyopathy, diabetic cardiomyopathy, cardiac arrhythmias
- MeSH terms
- Antifibrotic Agents, Animals, Extracellular Matrix, Fibroblasts, Fibrosis, Humans, Cardiomyopathies, Myocytes, Cardiac, Mechanotransduction, Cellular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.